Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-ALPP CART-cells in ALPP-Positive Advanced Solid Tumor
NCT04627740Phase 2Completed
- Sponsor
- Xinqiao Hospital
- Start
- Dec 2020
- Primary completion
- Feb 2025
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ALPP CAR-T cells in solid tumor, sponsored by Xinqiao Hospital. Started Dec 2020; status: completed.
02
Drugs
ALPP CAR-T cells
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04627740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04627740.